Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 339

1.

Adverse Events Following Measles-Mumps-Rubella-Varicella Vaccination and the Case of Seizures: A Post Marketing Active Surveillance in Puglia Italian Region, 2017-2018.

Stefanizzi P, Stella P, Ancona D, Malcangi KN, Bianchi FP, De Nitto S, Ferorelli D, Germinario CA, Tafuri S.

Vaccines (Basel). 2019 Oct 7;7(4). pii: E140. doi: 10.3390/vaccines7040140.

2.

SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).

Langer CJ, Redman MW, Wade JL 3rd, Aggarwal C, Bradley JD, Crawford J, Stella PJ, Knapp MH, Miao J, Minichiello K, Herbst RS, Kelly K, Gandara DR, Papadimitrakopoulou VA.

J Thorac Oncol. 2019 Oct;14(10):1839-1846. doi: 10.1016/j.jtho.2019.05.029. Epub 2019 May 31.

PMID:
31158500
3.

Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer.

Heath E, Heilbrun L, Mannuel H, Liu G, Lara P, Monk JP, Flaig T, Zurita A, Mack P, Vaishampayan U, Stella P, Smith D, Bolton S, Hussain A, Al-Janadi A, Silbiger D, Usman M, Ivy SP.

Oncologist. 2019 Sep;24(9):1149-e807. doi: 10.1634/theoncologist.2019-0331. Epub 2019 May 31.

4.

Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients.

Gallone G, Armeni P, Verheye S, Agostoni P, Timmers L, Campo G, Ielasi A, Sgura F, Tarantini G, Rosseel L, Zivelonghi C, Leenders G, Stella P, Tebaldi M, Tespili M, D'Amico G, Baldetti L, Ponticelli F, Colombo A, Giannini F.

Eur Heart J Qual Care Clin Outcomes. 2019 May 24. pii: qcz027. doi: 10.1093/ehjqcco/qcz027. [Epub ahead of print]

PMID:
31124556
5.

Sex differences in characteristics and outcome in acute coronary syndrome patients in the Netherlands.

Ten Haaf ME, Bax M, Ten Berg JM, Brouwer J, Van't Hof AW, van der Schaaf RJ, Stella PR, Tjon Joe Gin RM, Tonino PA, de Vries AG, Zijlstra F, Boersma E, Appelman Y.

Neth Heart J. 2019 May;27(5):263-271. doi: 10.1007/s12471-019-1271-0.

6.

Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement.

Abawi M, van Gils L, Agostoni P, van Mieghem NM, Kooistra NHM, van Dongen CS, van Jaarsveld RC, de Jaegere PPT, Doevendans PAFM, Stella PR.

Catheter Cardiovasc Interv. 2019 Mar 22. doi: 10.1002/ccd.28175. [Epub ahead of print]

PMID:
30901147
7.

Incidence, angiographic and clinical predictors, and impact of stent thrombosis: a 6-year survey of 6,545 consecutive patients.

Rozemeijer R, Wing Wong C, Leenders G, Timmers L, Koudstaal S, Rittersma SZ, Kraaijeveld A, Bots M, Doevendans P, Stella P, Voskuil M.

Neth Heart J. 2019 Jun;27(6):321-329. doi: 10.1007/s12471-019-1253-2.

8.

Ex Vivo Pilot Study of Cardiac Magnetic Resonance Velocity Mapping for Quantification of Aortic Regurgitation in a Porcine Model in the Presence of a Transcatheter Heart Valve.

Kooistra NHM, Nijhoff F, Abawi M, Agostoni P, Araya Roos DM, van Tuijl S, Blanken N, Voskuil M, Doevendans PAFM, Stella PR, Leiner T.

J Cardiovasc Transl Res. 2019 Aug;12(4):310-320. doi: 10.1007/s12265-019-09878-1. Epub 2019 Mar 15.

9.

Local Ultrasound-Facilitated Thrombolysis in High-Risk Pulmonary Embolism: First Dutch Experience.

de Winter MA, Hart EA, van den Heuvel DAF, Moelker A, Lely RJ, Kaasjager KAH, Stella PR, Chamuleau SAJ, Kraaijeveld AO, Nijkeuter M.

Cardiovasc Intervent Radiol. 2019 Jul;42(7):962-969. doi: 10.1007/s00270-019-02200-1. Epub 2019 Mar 12.

10.

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting.

Meneghini LF, Mauricio D, Orsi E, Lalic NM, Cali AMG, Westerbacka J, Stella P, Candelas Dea C, Pilorget V, Perfetti R, Khunti K; DUNE investigators.

Diabetes Obes Metab. 2019 Jun;21(6):1429-1436. doi: 10.1111/dom.13673. Epub 2019 Mar 28.

11.

One-year clinical outcomes of patients treated with polymer-free amphilimus-eluting stents or zotarolimus-eluting stents: A propensity-score adjusted analysis.

Rozemeijer R, van Muiden IG, Koudstaal S, Leenders GE, Timmers L, Rittersma SZ, Kraaijeveld AO, Doevendans PA, Voskuil M, Stella PR.

Catheter Cardiovasc Interv. 2019 Jul 1;94(1):61-69. doi: 10.1002/ccd.28041. Epub 2019 Jan 2.

12.

Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Mangat PK, Halabi S, Bruinooge SS, Garrett-Mayer E, Alva A, Janeway KA, Stella PJ, Voest E, Yost KJ, Perlmutter J, Pinto N, Kim ES, Schilsky RL.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00122. Epub 2018 Jul 11.

13.

Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.

Rozemeijer R, Stein M, Voskuil M, van den Bor R, Frambach P, Pereira B, Koudstaal S, Leenders GE, Timmers L, Rittersma SZ, Kraaijeveld AO, Agostoni P, Roes KC, Doevendans PA, Stella PR; ReCre8 Study Investigators.

Circulation. 2019 Jan 2;139(1):67-77. doi: 10.1161/CIRCULATIONAHA.118.037707.

PMID:
30586704
14.

Perforated vs nonperforated acute appendicitis: evaluation of short-term surgical outcomes in an elderly population.

Rondelli F, De Rosa M, Stella P, Boni M, Ceccarelli G, Balzarotti R, Polistena A, Sanguinetti A, Bugiantella W, Avenia N.

Minerva Chir. 2018 Oct 9. doi: 10.23736/S0026-4733.18.07715-5. [Epub ahead of print]

15.

Postoperative Delirium in Individuals Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.

Abawi M, Pagnesi M, Agostoni P, Chiarito M, van Jaarsveld RC, van Dongen CS, Slooter AJC, Colombo A, Kooistra NHM, Doevendans PAFM, Latib A, Stella PR.

J Am Geriatr Soc. 2018 Dec;66(12):2417-2424. doi: 10.1111/jgs.15600. Epub 2018 Oct 8.

PMID:
30296342
16.

Clinical Challenges and Opportunities With Current Electronic Health Records: Practicing Oncologists' Perspective.

Patt D, Stella P, Bosserman L.

J Oncol Pract. 2018 Oct;14(10):577-579. doi: 10.1200/JOP.18.00306. Epub 2018 Sep 12. No abstract available.

PMID:
30207855
17.

Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis.

Twigg SM, Escalada J, Stella P, Merino-Trigo A, Lavalle-Gonzalez FJ, Cariou B, Meneghini LF.

Diabetes Ther. 2018 Oct;9(5):2043-2053. doi: 10.1007/s13300-018-0498-x. Epub 2018 Sep 10.

18.

Persistent foramen ovale closure in divers with a history of decompression sickness.

Koopsen R, Stella PR, Thijs KM, Rienks R.

Neth Heart J. 2018 Nov;26(11):535-539. doi: 10.1007/s12471-018-1153-x.

19.

Unravelment of Medtronic Onyx stent during bifurcation stenting using the jailed wire technique; An adverse effect of helical stent structure?

Leenders GE, Liew HB, Stella PR.

Cardiovasc Revasc Med. 2018 Dec;19(8S):58-59. doi: 10.1016/j.carrev.2018.03.016. Epub 2018 Mar 21.

PMID:
30115559
20.

More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.

Rosenstock J, Cheng A, Ritzel R, Bosnyak Z, Devisme C, Cali AMG, Sieber J, Stella P, Wang X, Frías JP, Roussel R, Bolli GB.

Diabetes Care. 2018 Oct;41(10):2147-2154. doi: 10.2337/dc18-0559. Epub 2018 Aug 13.

PMID:
30104294
21.

The Tryton® dedicated bifurcation stent: Five-year clinical outcomes.

Green PG, Stella PR, Kumsārs I, Dens J, Sonck J, Bennett J, Bethencourt A, López BR, Dudek D, van Geuns RJ, Ramcharitar S.

Cardiovasc Revasc Med. 2019 Apr;20(4):316-323. doi: 10.1016/j.carrev.2018.06.023. Epub 2018 Jul 4.

PMID:
30037716
22.

Coronary artery treatment with a urea-based paclitaxel-coated balloon: the European-wide FALCON all-comers DCB Registry (FALCON Registry).

Widder JD, Cortese B, Levesque S, Berliner D, Eccleshall S, Graf K, Doutrelant L, Ahmed J, Bressollette E, Zavalloni D, Piraino D, Roguin A, Scheller B, Stella PR, Bauersachs J.

EuroIntervention. 2019 Jul 20;15(4):e382-e388. doi: 10.4244/EIJ-D-18-00261.

23.

Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis.

Tirado-Conte G, Rodés-Cabau J, Rodríguez-Olivares R, Barbanti M, Lhermusier T, Amat-Santos I, Toggweiler S, Cheema AN, Muñoz-García AJ, Serra V, Giordana F, Veiga G, Jiménez-Quevedo P, Campelo-Parada F, Loretz L, Todaro D, Del Trigo M, Hernández-García JM, García Del Blanco B, Bruno F, de la Torre Hernández JM, Stella P, Tamburino C, Macaya C, Nombela-Franco L.

Circ Cardiovasc Interv. 2018 Mar;11(3):e005727. doi: 10.1161/CIRCINTERVENTIONS.117.005727.

PMID:
29870383
24.

E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors.

Lubner S, Feng Y, Mulcahy M, O'Dwyer P, Giang GY, Hinshaw JL, Deming D, Klein L, Teitelbaum U, Payne J, Engstrom P, Stella P, Meropol N, Benson A.

Oncologist. 2018 Sep;23(9):1006-e104. doi: 10.1634/theoncologist.2018-0294. Epub 2018 May 31.

25.

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102.

Kornblum N, Zhao F, Manola J, Klein P, Ramaswamy B, Brufsky A, Stella PJ, Burnette B, Telli M, Makower DF, Cheema P, Truica CI, Wolff AC, Soori GS, Haley B, Wassenaar TR, Goldstein LJ, Miller KD, Sparano JA.

J Clin Oncol. 2018 Jun 1;36(16):1556-1563. doi: 10.1200/JCO.2017.76.9331. Epub 2018 Apr 17.

PMID:
29664714
26.

PCI in Patients with Diabetes: Role of the Cre8 Drug-eluting Stent.

Byrne RA, Eeckhout E, Sardella G, Stella P, Verheye S.

Interv Cardiol. 2017 May;12(1):13-17. doi: 10.15420/icr.2016:28:2.

27.

Short versus long duration of dual antiplatelet therapy following drug-eluting stents: a meta-analysis of randomised trials.

Rozemeijer R, Voskuil M, Greving JP, Bots ML, Doevendans PA, Stella PR.

Neth Heart J. 2018 May;26(5):242-251. doi: 10.1007/s12471-018-1104-6.

28.

Evaluation of mitral regurgitation by an integrated 2D echocardiographic approach in patients undergoing transcatheter aortic valve replacement.

Jansen R, Wind AM, Cramer MJ, Nijhoff F, Agostoni P, Ramjankhan FZ, Suyker WJ, Stella PR, Chamuleau SAJ.

Int J Cardiovasc Imaging. 2018 Aug;34(8):1193-1204. doi: 10.1007/s10554-018-1328-y. Epub 2018 Mar 10.

PMID:
29524077
29.

Anomalous coronary artery originating from the opposite sinus of Valsalva (ACAOS), fractional flow reserve- and intravascular ultrasound-guided management in adult patients.

Driesen BW, Warmerdam EG, Sieswerda GT, Schoof PH, Meijboom FJ, Haas F, Stella PR, Kraaijeveld AO, Evens FCM, Doevendans PAFM, Krings GJ, van Dijk APJ, Voskuil M.

Catheter Cardiovasc Interv. 2018 Jul;92(1):68-75. doi: 10.1002/ccd.27578. Epub 2018 Mar 9.

PMID:
29521471
30.

Triple synchronous colorectal carcinoma.

De Rosa M, Rondelli F, Stella P, Boni M, Ermili F, Ceccarelli G.

ANZ J Surg. 2019 Jul;89(7-8):E329-E330. doi: 10.1111/ans.14452. Epub 2018 Mar 6. No abstract available.

PMID:
29510452
31.

A New Surgical Device for Anterograde Intraoperative Rectal Washout.

Rondelli F, Santinelli R, Stella P, Bugiantella W, Ceccarelli G, Balzarotti RC, De Rosa M, Avenia N.

Surg Innov. 2018 Jun;25(3):203-207. doi: 10.1177/1553350618759767. Epub 2018 Feb 23.

PMID:
29473452
32.

Rare device landing zone ruptures after transcatheter aortic valve implantation (TAVI).

van Rijswijk JW, Kraaijeveld AO, Voskuil M, Stella PR, Vink A.

Cardiovasc Pathol. 2018 Mar - Apr;33:70-71. doi: 10.1016/j.carpath.2018.01.006. Epub 2018 Feb 2. No abstract available.

PMID:
29459347
33.

Percutaneous closure of a combined ventricular septal defect and paravalvular regurgitation after transcatheter aortic valve implantation: case report.

Kooistra NHM, Krings GJ, Stella PR, Voskuil M.

Eur Heart J Case Rep. 2018 Feb 21;2(1):yty013. doi: 10.1093/ehjcr/yty013. eCollection 2018 Mar.

34.

Impact of mandibular third molar extraction in the second molar periodontal status: A prospective study.

Stella PEM, Falci SGM, Oliveira de Medeiros LE, Douglas-de-Oliveira DW, Gonçalves PF, Flecha OD, Dos Santos CRR.

J Indian Soc Periodontol. 2017 Jul-Aug;21(4):285-290. doi: 10.4103/jisp.jisp_79_17.

35.

First dutch experience of the accurate neo self-expanding supra-annular valve for valve-in-valve transcatheter aortic valve implantation.

Soon KH, Kooistra NHM, Voskuil M, Kraaijeveld AO, Stella PR.

Neth Heart J. 2018 Apr;26(4):219-220. doi: 10.1007/s12471-018-1087-3. No abstract available.

36.

N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.

Tan WW, Hillman DW, Salim M, Northfelt DW, Anderson DM, Stella PJ, Niedringhaus R, Bernath AM, Gamini SS, Palmieri F, Perez EA.

Ann Oncol. 2018 Oct 1;29(10):2150. doi: 10.1093/annonc/mdx811. No abstract available.

37.

The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3.

Yale JF, Pettus JH, Brito-Sanfiel M, Lavalle-Gonzalez F, Merino-Trigo A, Stella P, Chevalier S, Buzzetti R.

PLoS One. 2018 Jan 25;13(1):e0190579. doi: 10.1371/journal.pone.0190579. eCollection 2018.

38.

Intracardiac shunts following transcatheter aortic valve implantation: a multicentre study.

Amat-Santos IJ, Rojas P, Stella PR, Nombela-Franco L, Lezáun-Burgui R, Muñoz-García AJ, Serra V, Gutierrez-Ibanes E, Larman M, Rodriguez-Olivares R, Kooistra NHM, Gutiérrez H, San Román JA.

EuroIntervention. 2018 Apr 20;13(17):1995-2002. doi: 10.4244/EIJ-D-17-00737.

39.

Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.

Schiff D, Jaeckle KA, Anderson SK, Galanis E, Giannini C, Buckner JC, Stella P, Flynn PJ, Erickson BJ, Schwerkoske JF, Kaluza V, Twohy E, Dancey J, Wright J, Sarkaria JN.

Cancer. 2018 Apr 1;124(7):1455-1463. doi: 10.1002/cncr.31219. Epub 2018 Jan 3.

40.

Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study.

Gupta S, Wang H, Skolnik N, Tong L, Liebert RM, Lee LK, Stella P, Cali A, Preblick R.

Adv Ther. 2018 Jan;35(1):43-55. doi: 10.1007/s12325-017-0651-3. Epub 2018 Jan 8.

41.

Clinical outcomes of complex real-world diabetic patients treated with amphilimus sirolimus-eluting stents or zotarolimus-eluting stents: A single-center registry.

Rozemeijer R, Benedetto D, Kraaijeveld AO, Voskuil M, Stein M, Timmers L, Rittersma SZ, Agostoni P, Doevendans PA, Stella PR.

Cardiovasc Revasc Med. 2018 Jul;19(5 Pt A):521-525. doi: 10.1016/j.carrev.2017.10.011. Epub 2017 Oct 26.

PMID:
29137966
42.

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913.

Chinnaiyan P, Won M, Wen PY, Rojiani AM, Werner-Wasik M, Shih HA, Ashby LS, Michael Yu HH, Stieber VW, Malone SC, Fiveash JB, Mohile NA, Ahluwalia MS, Wendland MM, Stella PJ, Kee AY, Mehta MP.

Neuro Oncol. 2018 Apr 9;20(5):666-673. doi: 10.1093/neuonc/nox209.

43.

Evaluation of Cognitive Function Following Transcatheter Aortic Valve Replacement.

Abawi M, de Vries R, Stella PR, Agostoni P, Boelens DHM, van Jaarsveld RC, van Dongen CS, Doevendans PAFM, Emmelot-Vonk MH.

Heart Lung Circ. 2018 Dec;27(12):1454-1461. doi: 10.1016/j.hlc.2017.10.006. Epub 2017 Oct 20.

PMID:
29097068
44.

Access to magnetic resonance imaging of patients with magnetic resonance-conditional pacemaker and implantable cardioverter-defibrillator systems: results from the Really ProMRI study.

Celentano E, Caccavo V, Santamaria M, Baiocchi C, Melissano D, Pisanò E, Gallo P, Polcino A, Arena G, Patanè S, Senatore G, Licciardello G, Padeletti L, Vado A, Giorgi D, Pecora D, Stella P, Anaclerio M, Guastaferro C, Giovannini T, Giacopelli D, Gargaro A, Maglia G.

Europace. 2018 Jun 1;20(6):1001-1009. doi: 10.1093/europace/eux118.

PMID:
29016759
45.

The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes.

Verheye S, Vrolix M, Kumsars I, Erglis A, Sondore D, Agostoni P, Cornelis K, Janssens L, Maeng M, Slagboom T, Amoroso G, Jensen LO, Granada JF, Stella P.

JACC Cardiovasc Interv. 2017 Oct 23;10(20):2029-2037. doi: 10.1016/j.jcin.2017.06.021. Epub 2017 Sep 27.

46.

Hemorrhagic cystitis in pregnancy: Case report and review of the literature.

Stella P, Miranda A, Lopez S, Morosetti G, Piccione E, Angioli R, Capriglione S.

J Neonatal Perinatal Med. 2017;10(3):325-327. doi: 10.3233/NPM-16116. Review.

PMID:
28854509
47.

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).

Roussel R, d'Emden MC, Fisher M, Ampudia-Blasco FJ, Stella P, Bizet F, Cali AMG, Wysham CH.

Diabetes Obes Metab. 2018 Feb;20(2):448-452. doi: 10.1111/dom.13071. Epub 2017 Sep 14.

48.

Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry.

Sardella G, Stella P, Chiarito M, Leone AM, Balian V, Prosperi F, Sorropago G, Mancone M, Calcagno S, Briguori C, Stefanini GG.

Catheter Cardiovasc Interv. 2018 Apr 1;91(5):884-891. doi: 10.1002/ccd.27187. Epub 2017 Jul 14.

PMID:
28707375
49.

Totally implantable venous access devices in children with medical complexity: preliminary data from a tertiary care hospital.

Geremia C, De Ioris MA, Crocoli A, Adorisio O, Scrocca R, Lombardi MH, Staccioli S, Stella P, Amendola P, Ciliento G, De Peppo F, Campana A.

J Vasc Access. 2017 Sep 11;18(5):426-429. doi: 10.5301/jva.5000727. Epub 2017 May 24.

PMID:
28574141
50.

Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.

Rozemeijer R, Stein M, Frambach P, Voskuil M, Kraaijeveld AO, Rodríguez-Olivares R, Timmers L, Pereira B, Rittersma SZ, Agostoni P, Doevendans PA, Stella PR.

Catheter Cardiovasc Interv. 2018 Feb 15;91(3):410-416. doi: 10.1002/ccd.27142. Epub 2017 May 22.

PMID:
28544782

Supplemental Content

Loading ...
Support Center